Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 50 and 80 years old (inclusive) at the time of signing the consent form
- People whose smoking history and age meet the screening guidelines set by the U.S. Preventive Services Task Force (USPSTF) for low-dose CT lung screening (confirm with trial site)
- People who are current or former patients at UI Health or Mile Square FQHC, including primary care and substance use disorder clinics
- People who have smoked at least 20 pack-years and either currently smoke or stopped smoking within the last 15 years (a "pack-year" means smoking one pack of cigarettes per day for one year)
- People who are able to sign a written consent form and a privacy authorization form themselves — consent from another person on the participant's behalf is not allowed under this trial
- Women who could become pregnant must not be currently pregnant or breastfeeding, and a pregnancy test will be required
- People who are able to understand and follow the study procedures for the full duration of the trial
Who may not be able to join:
- People who smoked for more than 20 pack-years but stopped smoking 15 or more years ago
- People who are currently being investigated or referred for further testing because a doctor suspects they may have cancer (for example, referred to an oncologist or scheduled for a biopsy based on a suspicious scan)
- People who have been diagnosed with a serious cancer (solid tumour or blood cancer) within the past 5 years, or who were diagnosed more than 5 years ago but never received treatment — note that people with a history of non-spreading basal cell carcinoma or squamous cell carcinoma of the skin are not excluded
- People who received active treatment for a serious cancer (solid tumour or blood cancer) within the past 5 years — note that ongoing hormone therapy for cancer (such as for breast or prostate cancer) does not automatically exclude someone (confirm with trial site)
- People who are unlikely to be able to follow the study procedures
- People who are not currently registered patients at UI Health (UIH)
- People who are currently pregnant (based on self-report)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ameen Salahudeen, MD, PhD, University of Illinois at Chicago
Phone: (312) 355-1625
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient Reported Outcomes Measurement Information System (PROMIS) survey results before and following the return of results (ROR); Multidimensional Impact of Cancer Risk Assessment (MICRA) following return of results (ROR); Perceptions and health beliefs relating to lung cancer screening using the Lung Health Belief Scale (Lung-HBS) perceived risk and perceived benefits after the return of results (ROR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.